[Prognosis and Related Factors of Patients with Pathological Complete Response after Neoadjuvant Therapy for Gastric Cancer].

Objective To investigate the related factors of pathological complete response(pCR)of patients with gastric cancer treated by neoadjuvant therapy and resection,and to analyze the risk factors of prognosis. Methods The clinical and pathological data of 490 patients with gastric cancer who received neoadjuvant therapy followed by radical gastrectomy from January to December in 2008 were retrospectively analyzed.Univariate and multivariate analyses were performed to identify the risk factors affecting pCR and prognosis. Results Among the 490 patients,41 achieved pCR,and the overall pCR rate was 8.3%(41/490).The pCR rate was 16.0% in the neoadjuvant chemoradiation group and 6.4% in the neoadjuvant chemotherapy group.The results of multivariate analysis showed that neoadjuvant chemoradiation(=4.401,95% =2.023-9.574,<0.001)and preoperative therapeutic response as partial response(=40.492,95% =5.366-305.572,<0.001)were independent predictors of pCR after neoadjuvant therapy.Multivariate analysis of prognosis showed that poorly differentiated tumor(=1.809,95% =1.104-2.964,=0.019),gastric cardia-fundus-body tumor(=2.025,95% =1.497-2.739,<0.001),≤15 intraoperative dissected lymph nodes(=1.482,95% =1.059-2.073,=0.022),and postoperative complications(=1.625,95% =1.156-2.285,=0.005)were independent risk factors for prognosis,while pCR(=0.153,95% =0.048-0.484,=0.001)and postoperative adjuvant chemotherapy(=0.589,95% =0.421-0.823,<0.001)were independent protective factors of prognosis. Conclusions Patients who achieved pCR after neoadjuvant therapy for locally advanced gastric cancer might have promising long-term survival,and pCR is an independent predictor for overall survival.Compared with chemotherapy alone,preoperative chemoradiotherapy can significantly improve the pCR rate of patients with locally advanced gastric cancer.